Healthcare and Life Science
Snakes and Ladders - navigating your investment journey
A workshop for tech founders and directors who are new to the investment journey. ...
Strong growth trajectory for AstraZeneca as it reports 9M and Q3 2023 results
Pascal Soriot, Chief Executive Officer, AstraZeneca, commenting on the results said: “Our company continued its strong growth trajectory in the third quarter with Total Revenue from our non‑COVID-19 medicines up 13% compared to last year. ...
Yourgene Health and Laboriad launch non-invasive prenatal testing in Morocco
Yourgene Health installs first NIPT platform, the IONA test, in Morrocco, enabling Laboriad to offer safe, fast and accurate prenatal testing to expectant parents ...
Neurosurgeon Hutch lands top research award
A Cambridge University Hospital’s expert has won an award often described as the “Nobel Prize of Neurosurgery”. ...
Lario Therapeutics receives “Company Making a Difference Award” from CDLK5 Forum, recognising its unique approach to precision medicine for genetic epilepsies
CDLK5 Forum Award for Excellence - Company Making a Difference 2023 Pre-clinical” presented by the Loulou Foundation at the CDKL5 Forum, 6th-7th November in London First-in-class ion channel inhibitors show promise as anti-seizure therapeutics for multiple treatment-resistant epileps...
Leading urology clinic in France installs Versius to accelerate its robotic surgery programme
Clinique Urologique Nantes-Atlantis will use Versius for cancerous and benign urological procedures. ...
Enhanc3D Genomics expands leadership team with the appointment of Hazel Jones as Chief Operating Officer
Cambridge, UK - Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, announces the appointment of Hazel Jones as Chief Operating Officer. ...
Polygenic scores: why one size does not fit all - podcast and new briefings
Opinions on whether polygenic scores should be used in health care - imminently or in the longer term - seem to be divided, with stakeholders, at least in the public domain, tending to one side or the other. ...
CN Bio appoints Neil Rumbelow as Director of Product Development
Key senior appointment to drive research and development activities for portfolio of PhysioMimix OOC microphysiological systems Cambridge, UK, 02 November 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single-and multi-organ microphysiological syste...
Inhibrx milestone triggers payment to Arecor under license agreement
Arecor Therapeutics plc Cambridge, UK, 2 November 2023. Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company advancing today’s therapies to enable healthier lives, announces the triggering of a milestone payment from Inhibrx Inc. (“Inhibrx”), for a novel enhanced formulat...